|
|
|
42
|
A2712
|
FML LIQUIFILM 0.1% EYE DR (ALL) FLUOROME
|
FLUOROMETHOLONE
|
FML LIQUIFILM
|
5ML
|
C
|
17.67
|
17.67
|
BOTT
|
0
|
BOTT
|
ALL
|
ALLERGAN INTERNATIONAL
|
COL
|
AVENTA BARBADOS
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
A271A
|
AFM 0.1% EYE DR (ARP/AHI) FLUOROMETHOLONE
|
FLUOROMETHOLONE
|
AFM
|
5ML
|
BQ
|
6.58
|
6.58
|
EYE DROP
|
0
|
BOTT
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
A271A
|
AFM 0.1% EYE DR (ARP) FLUOROMETHOLONE (BQ)
|
FLUOROMETHOLONE
|
AFM
|
5ML
|
BQ
|
7.42
|
7.421
|
BOTT
|
0
|
BOTT
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
41
|
A271C
|
E-FLOW 0.1% EYE DR (SHC) FLUOROMETHOLONE (BQ)
|
FLUOROMETHOLONE
|
E-FLOW
|
5ML
|
BQ
|
4.08
|
4.0775
|
BOTT
|
0
|
BOTT
|
SHC
|
SION HEALTHCARE
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
A271C
|
E-FLOW 0.1% EYE DR (SHC) FLUOROMETHOLONE
|
FLUOROMETHOLONE
|
E-FLOW
|
5ML
|
BQ
|
4.30
|
4.29
|
BOTT
|
0
|
BOTT
|
SHC
|
SION HEALTHCARE
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
A2921
|
ARAVA 20MG TAB (SFA/COL) LEFLUNOMIDE
|
LEFLUNOMIDE
|
ARAVA
|
30'S
|
C
|
95.14
|
3.17
|
TABLET
|
0
|
TAB
|
SFA
|
SANOFI AVENTIS
|
COL
|
COLLINS LTD
|
|
9236
|
DISEASE MODIFYING ANTIRHEUMATIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
A2921
|
ARAVA 20MG TAB (SFA) LEFLUNOMIDE (C)
|
LEFLUNOMIDE
|
ARAVA
|
30'S
|
C
|
95.14
|
3.1714
|
TAB
|
0
|
BOX
|
SFA
|
SANOFI AVENTIS
|
COL
|
COLLINS LTD
|
|
9236
|
DISEASE MODIFYING ANTIRHEUMATIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
DISEASE MODIFYING ANTIRHEUMATIC AGENTS
|
|
|
|
|
42
|
A2921
|
ARAVA 20MG TAB (SFA) LEFLUNOMIDE
|
LEFLUNOMIDE
|
ARAVA
|
30'S
|
C
|
95.14
|
3.17
|
TAB
|
0
|
BLIS
|
SFA
|
SANOFI
|
COL
|
AVENTA BARBADOS
|
|
9236
|
DISEASE MODIFYING ANTIRHEUMATIC AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
DISEASE MODIFYING ANTIRHEUMATIC AGENTS
|
|
|
|
|
40
|
A3131
|
SAIZEN 6MG INJ (MEK/COL) SOMATROPIN
|
SOMATROPIN
|
SAIZEN
|
VIAL
|
C
|
247.10
|
247.10
|
INJECTION
|
0
|
VIAL
|
MEK
|
MERCK SERONO
|
COL
|
COLLINS LTD
|
|
683004
|
SOMATROPHIN AGONIST
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
40
|
A321AH
|
VENLAFAXINE ER 37.5MG TAB (APL/AHI) VENLAFAXI
|
VENLAFAXINE
|
VENLAFAXINE ER
|
30'S
|
BP
|
10.90
|
0.36
|
TABLET
|
0
|
TAB
|
APL
|
AUROBINDO PHARMA LTD.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160416
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A321AJ
|
VENLAFAXINE 37.5MG TAB (ZYD)
|
VENLAFAXINE
|
VENLAFAXINE
|
100'S
|
BP
|
11.1451
|
0.1115
|
TAB
|
42
|
BOTT
|
ZYD
|
ZYDUS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
42
|
A321AJ
|
VENLAFAXINE 37.5MG TAB (ZYD)
|
VENLAFAXINE
|
VENLAFAXINE
|
100'S
|
BP
|
12.15
|
0.12
|
TAB
|
42
|
BLIS
|
ZYD
|
ZYDUS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
42
|
A321AK
|
APO-SERTRALINE 50MG CAP (APO)
|
SERTRALINE
|
APO-SERTRALINE
|
100'S
|
A
|
12.15
|
0.12
|
CAP
|
42
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
42
|
A321AL
|
ZOLOFT 50MG TAB (PFI) SERTRALINE
|
SERTRALINE
|
ZOLOFT
|
14'S
|
C
|
19.68
|
1.41
|
TAB
|
42
|
BLIS
|
PFI
|
PFIZER CORPORATION
|
COL
|
AVENTA BARBADOS
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
42
|
A321AR
|
PAXIL 12.5MG CR CAP (GSK) PAROXETINE
|
PAROXETINE
|
PAXIL
|
30'S
|
C
|
53.99
|
1.80
|
CAP
|
0
|
BLIS
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
|
28160492
|
ANTIDEPRESSANTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
ANTIDEPRESSANTS MISCELLANEOUS
|
|
|
|
|
42
|
A321AS
|
LEEPAROX 12.5MG CR TAB (JLP) PAROXETINE
|
PAROXETINE
|
LEEPAROX
|
100'S
|
BP
|
13.18
|
0.13
|
TAB
|
0
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160492
|
ANTIDEPRESSANTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
ANTIDEPRESSANTS MISCELLANEOUS
|
|
|
|
|
42
|
A321AT
|
SETMAX 50MG TAB (JLP) SERTRALINE
|
SERTRALINE
|
SETMAX
|
10X10
|
A
|
12.23
|
0.12
|
TAB
|
42
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160492
|
ANTIDEPRESSANTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTIDEPRESSANTS MISCELLANEOUS
|
|
|
|
|
40
|
A321S
|
VENLAFAXINE SR 37.5MG CAP (CIP/AHI)
|
VENLAFAXINE
|
VENLAFAXINE SR
|
100'S
|
BP
|
35.20
|
0.35
|
CAPSULE
|
0
|
CAP
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160416
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A3221
|
APO-FLUOXETINE 20MG CAP (APO/COL)
|
FLUOXETINE
|
APO-FLUOXETINE
|
100'S
|
A
|
7.61
|
0.08
|
CAPSULE
|
120
|
CAP
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
42
|
A3221
|
APO-FLUOXETINE 20MG CAP (APO)
|
FLUOXETINE
|
APO-FLUOXETINE
|
100'S
|
A
|
7.77
|
0.08
|
CAP
|
120
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|